Tat inhibitor (National Institute of Neurological Disorders and Stroke/Matinas)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTat inhibitor (National Institute of Neurological Disorders and Stroke/Matinas)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Neurological Disorders And Stroke
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMatinas Biopharma Holdings IncNational Institute Of Neurological Disorders And Stroke
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A